To evaluate ATP7A’s role in glioma stemness in vivo, intracranial limiting dilution assays (10,000–100 cells) showed that ATP7A knockdown extended survival, indicating reduced tumor initiation (Supplemental Figure 10B). Here, ATP7A is linked to glioma.